GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Average Rating of “Moderate Buy” from Analysts

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has earned an average rating of “Moderate Buy” from the eighteen analysts that are covering the stock, Marketbeat reports. Nine equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $80.2105.

Several research analysts recently issued reports on the stock. Jefferies Financial Group dropped their price target on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Rothschild & Co Redburn dropped their price objective on shares of GE HealthCare Technologies from $110.00 to $98.00 in a report on Thursday, April 30th. Barclays dropped their price objective on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a report on Thursday, April 30th. Mizuho dropped their price objective on shares of GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. Finally, BNP Paribas Exane dropped their price objective on shares of GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $64.23 on Monday. GE HealthCare Technologies has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $29.22 billion, a PE ratio of 15.37, a price-to-earnings-growth ratio of 1.45 and a beta of 0.74. The firm has a 50-day moving average price of $68.45 and a 200 day moving average price of $76.26.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same period last year, the company earned $1.01 EPS. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts anticipate that GE HealthCare Technologies will post 4.89 earnings per share for the current fiscal year.

Insider Activity at GE HealthCare Technologies

In other news, CEO Peter J. Arduini acquired 4,169 shares of the company’s stock in a transaction dated Thursday, April 30th. The stock was bought at an average price of $59.92 per share, with a total value of $249,806.48. Following the completion of the acquisition, the chief executive officer owned 259,424 shares in the company, valued at approximately $15,544,686.08. This represents a 1.63% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO James Saccaro acquired 3,310 shares of the company’s stock in a transaction dated Friday, May 1st. The shares were purchased at an average cost of $60.60 per share, with a total value of $200,586.00. Following the acquisition, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This represents a 3.93% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders have acquired 11,847 shares of company stock valued at $719,555. Insiders own 0.36% of the company’s stock.

Institutional Trading of GE HealthCare Technologies

Several hedge funds have recently modified their holdings of GEHC. Laurel Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $26,000. Optima Capital LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Godfrey Financial Associates Inc. acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Montag A & Associates Inc. increased its holdings in shares of GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 262 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.